| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2026―Jan―28 |
Correction to: Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial |
|
| 2 |
[GO] |
2025―Okt―15 |
Time to anti-cancer treatment resumption after SARS-CoV-2 infection in patients with active haematological diseases undergoing combined antiviral treatments |
E Matteini, C Pinnetti, F Frondizi, E Rando, M Chiuchiarelli, E Metafuni, I Mastrorosa, E Alma, V Mazzotta, R Santangelo, S Marchetti, M Sanguinetti, S Sica, C Torti, A Antinori, A Cingolani |
| 3 |
[GO] |
2025―Sep―01 |
Placental transfer of medications to treat COVID-19, molnupiravir, favipiravir and nirmatrelvir/ritonavir, in the ex vivo human cotyledon model |
Solene Labaye, Fatima Djellali, Gilles Peytavin, Laurent Mandelbrot |
| 4 |
[GO] |
2025―Jun―27 |
Correction to: Pandemic human-associated extended-spectrum β-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs |
|
| 5 |
[GO] |
2025―Mai―14 |
Decline of antimicrobial resistance in Pseudomonas aeruginosa bacteraemia following the COVID-19 pandemic: a longitudinal observational study |
Yulia Butscheid, Pascal M Frey, Marc Pfister, Lisa Pagani, Roger D Kouyos, Thomas C Scheier, Willy I Staiger, Stefano Mancini, Silvio D Brugger |
| 6 |
[GO] |
2025―Mrz―19 |
Pandemic human-associated extended-spectrum β-lactamase-producing Escherichia coli lineages of ST38, ST131 and ST141 identified in Viennese dogs |
Pia Saria, Pavlos G Doulidis, Amélie Desvars-Larrive, Adrienn Gréta Tóth, Iwan A Burgener, Alexandro Rodríguez-Rojas, Olga Makarova |
| 7 |
[GO] |
2025―Jan―13 |
Efficacy and safety of antiviral therapies for the treatment of persistent COVID-19 in immunocompromised patients since the Omicron surge: a systematic review |
Caroline Hirsch, Nina Kreuzberger, Nicole Skoetz, Ina Monsef, Stefan Kluge, Christoph D Spinner, Jakob J Malin |
| 8 |
[GO] |
2025―Jan―13 |
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-omicron or omicron variants: a modelling analysis of the randomized DisCoVeRy trial-authors’ response |
Maxime Beaulieu, Jérémie Guedj |
| 9 |
[GO] |
2024―Nov―05 |
Comment on: Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial |
Alexis Lacout, Xavier Azalbert, Corinne Reverbel, Jean-François Lesgards, Dominique Cerdan, Valère Lounnas, Gérard Guillaume, Martin Zizi, Christian Perronne |
| 10 |
[GO] |
2024―Okt―07 |
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients-authors’ response |
Tzong-Yow Wu, Pao-Yu Chen, Jann-Tay Wang, Wang-Da Liu, Yee-Chun Chen, Shan-Chwen Chang |
| 11 |
[GO] |
2024―Okt―07 |
Real-world effectiveness of early anti-SARS therapy in severely immunocompromised COVID-19 outpatients during the SARS-CoV-2 omicron variant era: a propensity score-adjusted retrospective cohort study |
Héctor Pinargote-Celorio, Óscar Moreno-Pérez, Pilar González-De-La-Aleja, Jara Llenas-García, Pedro María Martínez Pérez-Crespo, Juan-Carlos Rodríguez-Díaz, Belén Martínez-López, Nicolás Merchante Gutiérrez, José-Manuel Ramos-Rincón, Esperanza Merino |
| 12 |
[GO] |
2024―Sep―27 |
Outcomes of patients hospitalized in ward settings for COVID-19 pneumonia with or without early empirical antibiotics |
A Kopp-Derouet, S Diamantis, S Chevret, A Tazi, R Burlacu, J P Kevorkian, J B Julla, J M Molina, P Sellier |
| 13 |
[GO] |
2024―Sep―09 |
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19 |
Jonathan A T Sandoe, Detelina Grozeva, Mahableshwar Albur, Stuart E Bond, Lucy Brookes-Howell, Paul Dark, Joanne Euden, Ryan Hamilton, Thomas P Hellyer, Josie Henley, Susan Hopkins, Philip Howard, Daniel Howdon, Chikezie Knox-Macaulay, Martin J Llewelyn, Wakunyambo Maboshe, Iain J McCullagh, Margaret Ogden, Helena K Parsons, David G Partridge, Neil Powell, Graham Prestwich, Dominick Shaw, Bethany Shinkins, Tamas Szakmany, Emma Thomas-Jones, Stacy Todd, Robert M West, Enitan D Carrol, Philip Pallmann |
| 14 |
[GO] |
2024―Sep―05 |
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial |
Maxime Beaulieu, Alexandre Gaymard, Clément Massonnaud, Nathan Peiffer-Smadja, Maude Bouscambert-Duchamp, Guislaine Carcelain, Guillaume Lingas, France Mentré, Florence Ader, Maya Hites, Pascal Poignard, Jérémie Guedj |
| 15 |
[GO] |
2024―Jul―29 |
Comment on: Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients |
Federico Barone, Andrea Giacomelli, Giacomo Casalini, Mario Corbellino, Alessia Lai, Andrea Gori, Spinello Antinori |
| 16 |
[GO] |
2024―Jul―10 |
Influence of the COVID-19 pandemic on the defined daily dose of antimicrobials in patients requiring elective and emergency surgical procedures |
Fátima Aguilar-Del-Castillo, Miriam Álvarez-Aguilera, José Tinoco-González, Iván Vaca, Laura Herrera-Hidalgo, María Paniagua, José Miguel Cisneros, Francisco Javier Padillo-Ruiz, Rosa M Jiménez-Rodríguez |
| 17 |
[GO] |
2024―Jul―10 |
Extended remdesivir administration in haematological patients with malignancies and COVID-19 during the Omicron era: safety and outcomes |
Emmanuelle Gras, Tommaso Francesco Aiello, Mariana Chumbita, Antonio Gallardo-Pizarro, Patricia Monzó-Gallo, Christian Teijón-Lumbreras, Maria Suárez-Lledó, Laura Magnano, Montse Tuset, Maria Ángeles Marcos, Alex Soriano, Carolina Garcia-Vidal |
| 18 |
[GO] |
2024―Jun―06 |
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study |
Edward J D Webb, Daniel Howdon, Rebecca Bestwick, Natalie King, Jonathan A T Sandoe, Joanne Euden, Detelina Grozeva, Robert West, Philip Howard, Neil Powell, Mahableshwar Albur, Stuart Bond, Lucy Brookes-Howell, Paul Dark, Thomas Hellyer, Martin Llewelyn, Iain J McCullagh, Margaret Ogden, Philip Pallmann, Helena Parsons, David Partridge, Dominick Shaw, Tamas Szakmany, Stacy Todd, Emma Thomas-Jones, Enitan D Carrol, Bethany Shinkins, Jonathan Sandoe, Enitan Carrol, Emma Thomas-Jones, Lucy Brookes-Howell, Josie Henley, Wakunyambo Maboshe, Philip Pallmann, Detelina Grozeva, Marcin Bargiel, Judith Evans, Edward Webb, Rebecca Bestwick, Daniel Howdon, Robert West, Colin Richman, Sarah Gerver, Russell Hope, Susan Hopkins, Margaret Heginbothom, Philip Howard, Jonathan Sandoe, Claire Berry, Georgina Davis, Vikki Wilkinson, Stacy Todd, Eleanor Taylor-Barr, Mary Brodsky, Jo Brown, Jenni Burns, Sharon Glynn, Alvyda Gureviciute, Megan Howard, Jennifer Kirkpatrick, Hannah Murphy, Emma Richardson, Deborah Scanlon, Claire Small, Graham Sweeney, Lisa Williams, Tamas Szakmany, Evelyn Baker, Yusuf Cheema, Jill Dunhill, Charlotte Killick, Charlie King, Simran Kooner, Swyn Lewis, Maxine Nash, Owen Richardson, Jemma Tuffney, Clare Westacott, Sarah Williams, David Partridge, Helena Parsons, Kay Cawthron, Yuen Kiu Tai, Thomas Newman, Megan Plowright, Helen Shulver, Anna Sivakova, Neil Powell, Freddie Ayliffe, Emma Darke, Eve Fletcher, Fiona Hammonds, Gladys Marquez, Leanne Welch, Stuart Bond, Jade Lee-Milner, Joseph Spencer, Mahableshwar Albur, Rodrigo Brandao, Joshua Hrycaiczuk, Jack Stanley, Martin Llewelyn, Elizabeth Cross, Daniel Hansen, Ethan Redmore, Abigail Whyte, Tom Hellyer, Iain McCullagh, Benjamin Brown, Michele Calabrese, Cameron Cole, Jessica DeSousa, Leigh Dunn, Stephanie Grieveson, Arti Gulati, Elizabeth Issac, Ruaridh Mackay, Fatima Simoes, Paul Dark, Elena Apatri, Bethan Charles, Helen Christensen, Alice Harvey, Diane Lomas, Melanie Taylor, Vicky Thomas, Danielle Walker, Dominick Shaw, Lucy Howard, Amelia Joseph, Saheer Sultan, Chikezie Knox-Macaulay, Margaret Ogden, Graham Prestwich, Ryan Hamilton |
| 19 |
[GO] |
2024―Mai―31 |
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies |
Yonatan M Mesfin, Joseph E Blais, Kelemu Tilahun Kibret, Teketo Kassaw Tegegne, Benjamin J Cowling, Peng Wu |
| 20 |
[GO] |
2024―Mai―09 |
Comment on: Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients |
I Wen Chen, Li-Chen Chang, Kuo-Chuan Hung |
| 21 |
[GO] |
2024―Apr―11 |
Human bronchopulmonary disposition and plasma pharmacokinetics of oral bemnifosbuvir (AT-527), an experimental guanosine nucleotide prodrug for COVID-19 |
Xiao-Jian Zhou, Arantxa Horga, Adeep Puri, Lee Winchester, Maureen Montrond, Keith Pietropaolo, Bruce Belanger, Courtney V Fletcher, Janet Hammond |
| 22 |
[GO] |
2024―Mrz―28 |
Suboptimal response to combination therapy with tixagevimab/cilgavimab and remdesivir for persistent SARS-CoV-2 infections in immunocompromised patients |
Tzong-Yow Wu, Pao-Yu Chen, Jann-Tay Wang, Wang-Da Liu, Yee-Chun Chen, Shan-Chwen Chang |
| 23 |
[GO] |
2024―Feb―22 |
The relationship between viral clearance rates and disease progression in early symptomatic COVID-19: a systematic review and meta-regression analysis |
Shivani Singh, Simon Boyd, William H K Schilling, James A Watson, Mavuto Mukaka, Nicholas J White |
| 24 |
[GO] |
2024―Feb―21 |
COVID-19 hospitalization risk after outpatient nirmatrelvir/ritonavir use, January to August 2022, North Carolina |
Heather I Henderson, David A Wohl, William A Fischer, Luther A Bartelt, David van Duin, Deana M Agil, Lindsay E Browne, Kuo-Ping Li, Amanda Moy, Joseph J Eron, Sonia Napravnik |
| 25 |
[GO] |
2023―Dez―12 |
Nirmatrelvir/ritonavir for COVID-19: an overview of systematic reviews |
Mario Cruciani, Ilaria Pati, Francesca Masiello, Simonetta Pupella, Vincenzo De Angelis |
| 26 |
[GO] |
2023―Nov―23 |
SARS-CoV-2 genomics and impact on clinical care for COVID-19 |
Ramon Lorenzo-Redondo, Alexandre Machado de Sant’Anna Carvalho, Judd F Hultquist, Egon A Ozer |
| 27 |
[GO] |
2023―Nov―23 |
An overview of COVID-19 global epidemiology and discussion of potential drivers of variable global pandemic impacts |
Polly Ashmore, Emma Sherwood |
| 28 |
[GO] |
2023―Nov―23 |
Innovative approaches to COVID-19 medical countermeasure development |
Gavin H Harris, Amesh A Adalja |
| 29 |
[GO] |
2023―Nov―23 |
COVID-19 therapeutics: stewardship in England and considerations for antimicrobial resistance |
Sabine Bou-Antoun, Sakib Rokadiya, Diane Ashiru-Oredope, Alicia Demirjian, Emma Sherwood, Nicholas Ellaby, Sarah Gerver, Carlota Grossi, Katie Harman, Hassan Hartman, Alessandra Lochen, Manon Ragonnet-Cronin, Hanna Squire, J Mark Sutton, Simon Thelwall, Julia Tree, Mohammad W Bahar, David I Stuart, Colin S Brown, Meera Chand, Susan Hopkins |
| 30 |
[GO] |
2023―Nov―23 |
The evaluation of a multi-day testing approach with antigen lateral flow devices for people eligible for community-based COVID-19 treatments |
Tom Fowler, Alasdair Fellows, Rachael MacISaac, Olumide Kolade, Bhupinder Singh, Adam Eccles, Edward Blandford, Sarah A Tunkel |
| 31 |
[GO] |
2023―Nov―23 |
Lessons identified for a future pandemic |
Neil Cunningham, Susan Hopkins |
| 32 |
[GO] |
2023―Okt―26 |
Prevalence of antibiotic prescribing in COVID-19 patients in China and other low- and middle-income countries during the pandemic (December 2019-March 2021): a systematic review and meta-analysis |
Wenjuan Cong, Hung-Yuan Cheng, Beth Stuart, Binjuan Liu, Yunyi Tang, Yi Wang, Nour AIhusein, Hexing Wang, Amit Manchundiya, Helen Lambert |
| 33 |
[GO] |
2023―Okt―26 |
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients-authors’ response |
Mingyao Sun, Honghao Lai, Zhigang Zhang, Long Ge |
| 34 |
[GO] |
2023―Sep―27 |
Correction to: Effect of dapagliflozin on COVID-19 infection and risk of hospitalization |
|
| 35 |
[GO] |
2023―Sep―18 |
Effects of remdesivir on SARS-CoV-2 viral dynamics and mortality in viraemic patients hospitalized for COVID-19 |
Karl Hagman, Magnus Hedenstierna, Jacob Widaeus, Emelie Arvidsson, Berit Hammas, Lena Grillner, Jan Jakobsson, Patrik Gille-Johnson, Johan Ursing |
| 36 |
[GO] |
2023―Sep―13 |
Is molnupiravir a wise investment? Reassessing COVID-19 treatment strategies |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 37 |
[GO] |
2023―Aug―24 |
Impact of the COVID-19 pandemic on community antibiotic consumption in the EU/European Economic Area: a changepoint analysis |
Helene Vermeulen, Niel Hens, Lucy Catteau, Boudewijn Catry, Samuel Coenen |
| 38 |
[GO] |
2023―Aug―07 |
Effect of dapagliflozin on COVID-19 infection and risk of hospitalization |
Angel Salgado-Barreira, Jose Seijas-Amigo, Moises Rodriguez-Mañero, María Piñeiro-Lamas, Sonia Eiras, Alberto Cordero, Jose Ramon Gonzalez-Juanatey, Adolfo Figueiras |
| 39 |
[GO] |
2023―Jul―12 |
Molnupiravir for the treatment of non-severe COVID-19: a systematic review and meta-analysis of 14 randomized trials with 34 570 patients |
Mingyao Sun, Honghao Lai, Jiajie Huang, Jianing Liu, Ying Li, Jinhui Tian, Caiyun Zhang, Janne Estill, Zhigang Zhang, Long Ge |
| 40 |
[GO] |
2023―Mai―30 |
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients |
Sammy Huygens, Arvind Gharbharan, Yasmina Serroukh, Britt Snoek, Bas Franken, Bas B Oude Munnink, P Martin Van Hagen, Susanne Bogers, Corine H Geurtsvankessel, Bart J A Rijnders |
| 41 |
[GO] |
2023―Mai―25 |
Triple antiviral treatment for COVID-19 in an immunocompromised patient |
Chiara Dentone, Malgorzata Mikulska, Chiara Sepulcri, Elisa Balletto, Vanessa De Pace, Sabrina Beltramini, Matteo Bassetti |
| 42 |
[GO] |
2023―Mai―25 |
Non-randomized evaluation of hospitalization after a prescription for nirmatrelvir/ritonavir versus molnupiravir in high-risk COVID-19 outpatients |
Kelsie Cowman, Alexander Miller, Yi Guo, Mei H Chang, Terrence McSweeney, Hongkai Bao, Roxanne Simpson, Claire Braithwaite, Evans Sunu, Theary Ros, Maria Rodriguez, Eric Laboy, Linda Bard, Leslie Alsina, Angelica Cintron, Erin Andrews, Priya Nori |
| 43 |
[GO] |
2023―Mai―12 |
Efficacy and safety of molnupiravir for the treatment of SARS-CoV-2 infection: a systematic review and meta-analysis |
Jakob J Malin, Stephanie Weibel, Henning Gruell, Nina Kreuzberger, Miriam Stegemann, Nicole Skoetz |
| 44 |
[GO] |
2023―Apr―22 |
Real-life experience with remdesivir for treatment of COVID-19 among older adults: a multicentre retrospective study |
Ili Margalit, Giusy Tiseo, Marco Ripa, Vanni Borghi, Hefziba Green, Virginie Prendki, Niccolò Riccardi, Giovanni Battista Perego, Alessandro Grembiale, Laura Galli, Marco Tinelli, Antonella Castagna, Cristina Mussini, Marco Falcone, Dafna Yahav |
| 45 |
[GO] |
2023―Apr―13 |
Current outcomes of SARS-CoV-2 Omicron variant infection in high-risk haematological patients treated early with antivirals |
Tommaso-Francesco Aiello, Pedro Puerta-Alcalde, Mariana Chumbita, Carlos Lopera, Patricia Monzó, Albert Cortes, Francesc Fernández-Avilés, María Suárez-Lledó, Juan Correa, Valentín Ortiz-Maldonado, Genoveva Cuesta, Nuria Martinez-Cibrian, Jordi Esteve, Maria Ángeles Marcos, Josep Mensa, Alex Soriano, Carolina Garcia-Vidal |
| 46 |
[GO] |
2023―Apr―11 |
Correction: The use of prophylactic nebulized liposomal amphotericin B to reduce the risk of CAPA in mechanically ventilated COVID-19 patients on ICU in a large UK tertiary teaching hospital trust |
|
| 47 |
[GO] |
2023―Mrz―28 |
Point prevalence audit surveys of respiratory tract infection consultations and antibiotic prescribing in primary care before and during the COVID-19 pandemic in Ireland |
M Shah, A Fleming, T M Barbosa, A W van der Velden, S Parveen, A Vellinga |
| 48 |
[GO] |
2023―Mrz―07 |
The use of prophylactic nebulized liposomal amphotericin B to reduce the risk of CAPA in mechanically ventilated COVID-19 patients on ICU in a large UK tertiary teaching hospital trust |
Anna Wild, Vicki Fleming, Lauren Rose, Amelia Joseph |
| 49 |
[GO] |
2023―Mrz―04 |
Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients |
Emily L Heil, Kimberly C Claeys, Ellen G Kline, Tara M Rogers, Kevin M Squires, Alina Iovleva, Yohei Doi, Mary Banoub, Mandee M Noval, Paul M Luethy, Ryan K Shields |
| 50 |
[GO] |
2023―Mrz―01 |
Comment on ‘The dangers of non-randomized, observational studies. Experience from the COVID-19 epidemic’. Aspirin therapy in COVID-19: too soon to dismiss its benefits? |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 51 |
[GO] |
2023―Feb―15 |
A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria |
Nikolaos Spernovasilis, Evangelos I Kritsotakis, Anna Mathioudaki, Alexandra Vouidaski, Christos Spanias, Maria Petrodaskalaki, Petros Ioannou, Georgios Chamilos, Diamantis P Kofteridis |
| 52 |
[GO] |
2023―Feb―10 |
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo |
Takayuki Kuroda, Haruaki Nobori, Keita Fukao, Kaoru Baba, Kazumi Matsumoto, Shinpei Yoshida, Yukari Tanaka, Ryosuke Watari, Ryoko Oka, Yasuyuki Kasai, Kae Inoue, Sho Kawashima, Alice Shimba, Yoko Hayasaki-Kajiwara, Miki Tanimura, Qianhui Zhang, Yuki Tachibana, Teruhisa Kato, Takao Shishido |
| 53 |
[GO] |
2023―Feb―06 |
Antimicrobial consumption and drug utilization patterns among COVID-19 and non-COVID-19 patients |
Bianca B P Antunes, Amanda A B Silva, Patricia H C Nunes, Ignacio Martin-Loeches, Pedro Kurtz, Silvio Hamacher, Fernando A Bozza |
| 54 |
[GO] |
2023―Jan―08 |
Evaluation of publication bias for 12 clinical trials of molnupiravir to treat SARS-CoV-2 infection in 13 694 patients with meta-analysis |
Jack M Lawrence, Manya Mirchandani, Andrew Hill |
| 55 |
[GO] |
2022―Dez―28 |
The dangers of non-randomized, observational studies: experience from the COVID-19 epidemic |
Andrew Hill, Manya Mirchandani |
| 56 |
[GO] |
2022―Dez―22 |
Successful use of nirmatrelvir/ritonavir in immunocompromised patients with persistent and/or relapsing COVID-19 |
Lucia Graziani, Leonardo Gori, Tommaso Manciulli, Gregorio Basile, Irene Campolmi, Beatrice Borchi, Marta di Dio, Marta Mattei, Greta Ciurleo, Maria Ciliberti, Francesca Malentacchi, Marco Coppi, Alessandro Morettini, Paola Parronchi, Gian Maria Rossolini, Alessandro Bartoloni, Sara Tomassetti, Michele Spinicci |
| 57 |
[GO] |
2022―Okt―25 |
Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021 |
Martin Ho, Mina Tadrous, Anita Iacono, Katie Suda, Tara Gomes |
| 58 |
[GO] |
2022―Sep―02 |
Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data-authors’ response |
Martin J Llewelyn, Robert M West, Enitan D Carrol, Philip Pallmann, Jonathan A T Sandoe |
| 59 |
[GO] |
2022―Aug―18 |
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)-authors’ response |
Tumader Khouja, Mina Tadrous, Katie J Suda |
| 60 |
[GO] |
2022―Aug―12 |
Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection |
Simiso Sokhela, Bronwyn Bosch, Andrew Hill, Bryony Simmons, Joana Woods, Hilary Johnstone, Godspower Akpomiemie, Leah Ellis, Andrew Owen, Carmen Perez Casas, Willem Daniel Francois Venter |
| 61 |
[GO] |
2022―Aug―01 |
Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge |
Nicholas Piccicacco, Kristen Zeitler, Austin Ing, Jose Montero, Jonathan Faughn, Suzane Silbert, Kami Kim |
| 62 |
[GO] |
2022―Aug―01 |
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model |
Haruaki Nobori, Keita Fukao, Takayuki Kuroda, Naomi Anan, Ryoichi Tashima, Masaaki Nakashima, Sayuri Noda, Minako Tajiri, Mikinori Torii, Shinsuke Toba, Kentaro Uemura, Takao Sanaki, Takao Shishido, Yuki Tachibana, Teruhisa Kato |
| 63 |
[GO] |
2022―Jul―25 |
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19 |
Emmanuel Lafont, Hélène Pere, David Lebeaux, Geoffrey Cheminet, Eric Thervet, Romain Guillemain, Adrien Flahault |
| 64 |
[GO] |
2022―Jul―23 |
Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia |
Vera Vlahović-Palčevski, Igor Rubinić, Marina Payerl Pal |
| 65 |
[GO] |
2022―Jul―18 |
Interpatient variability in the pharmacokinetics of remdesivir and its main metabolite GS-441524 in treated COVID-19 subjects |
Massimo Tempestilli, Tommaso Ascoli Bartoli, Domenico Benvenuto, Giulia Valeria Stazi, Luisa Marchioni, Emanuele Nicastri, Chiara Agrati |
| 66 |
[GO] |
2022―Jun―09 |
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched study |
Daniel K. Nomah, Juliana Reyes-Urueña, Yesika Díaz, Sergio Moreno, Jordi Aceiton, Andreu Bruguera, Rosa M. Vivanco-Hidalgo, Jordi Casabona, Pere Domingo, Jordi Navarro, Arkaitz Imaz, Elisabet Deig, Gemma Navarro, Josep M. Llibre, Jose M. Miro, Esteve Muntada, Anna Esteve, Francisco Fanjul, Vicenç Falcó, Hernando Knobel, Josep Mallolas, Juan Tiraboschi, Adrià Curran, Joaquín Burgos, Boris Revollo, Maria Gracia, Maria del Mar Gutierrez, Javier Murillas, Francisco Homar, Jose V. Fernández-Montero, Eva González, Joaquim Peraire, Lluís Force, Elena Leon, Miquel Hortos, Ingrid Vilaró, Amat Orti, David Dalmau, Àngels Jaen, Elisa De Lazzari, Leire Berrocal, Lucía Rodríguez, Freya Gargoulas, Toni Vanrell, Jose Carlos, Josep Vilà, Marina Martínez, Bibiana Morell, Maribel Tamayo, Jorge Palacio, Juan Ambrosioni, Montse Laguno, María Martínez-Rebollar, José L. Blanco, Felipe Garcia, Berta Torres, Lorena de la Mora, Alexy Inciarte, Ainoa Ugarte, Iván Chivite, Ana González-Cordon, Lorna Leal, Antoni Jou, Eugènia Negredo, Maria Saumoy, Ana Silva, Sofia Scévola, Paula Suanzes, Patricia Alvarez, Isabel Mur, Melchor Riera Jaume, Mercedes García-Gasalla, Maria À. Ribas, Antoni A. Campins, María Peñaranda, María L. Martin, Helem Haydee, Sònia Calzado, Manel Cervantes, Marta Navarro, Antoni Payeras, Carmen Cifuentes, Aroa Villoslada, Patrícia Sorní, Marta Molero, Nadia Abdulghani, Thaïs Comella, Rocio Sola, Montserrat Vargas, Consuleo Viladés, Anna Martí, Elena Yeregui, Anna Rull, Pilar Barrufet, Laia Arbones, Elena Chamarro, Cristina Escrig, Mireia Cairó, Xavier Martinez-Lacasa, Roser Font, Lizza Macorigh, Juanse Hernández |
| 67 |
[GO] |
2022―Jun―07 |
Comment on: Impact of introducing procalcitonin testing on antibiotic usage in acute NHS hospitals during the first wave of COVID-19 in the UK: a controlled interrupted time series analysis of organization-level data |
Mei-Chin Su, James Yeongjun Park, Wan-Ting Hsu, Chung-Yen Huang, Chia-Chun Hsu, Chia-Hung Yo, Chien-Chang Lee |
| 68 |
[GO] |
2022―Mai―31 |
Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19) |
Giorgia Sulis, Madhukar Pai, Sumanth Gandra |
| 69 |
[GO] |
2022―Apr―02 |
Correction to: Drug interactions: a review of the unseen danger of experimental COVID-19 therapies |
|
| 70 |
[GO] |
2021―Mrz―11 |
Erratum to: Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis |
Bryony Simmons, Hannah Wentzel, Sara Mobarak, Gholamali Eslami, Anahita Sadeghi, Ali Ali Asgari, Hamideh Abbaspour Kasgari, Hafez Tirgar Fakheri, Shahin Merat, Andrew Hill |
| 71 |
[GO] |
2020―Nov―19 |
Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers |
Boris Revollo, Cristian Tebe, Judith Peñafiel, Ignacio Blanco, Nuria Perez-Alvarez, Ruth Lopez, Laura Rodriguez, Josep Ferrer, Pilar Ricart, Enrique Moret, Cristina Tural, Anna Carreres, Joan Matllo, Sebastià Videla, Bonaventura Clotet, Josep M Llibre |
| 72 |
[GO] |
2020―Mai―18 |
COVID-19 and the potential long-term impact on antimicrobial resistance |
Timothy M Rawson, Luke S P Moore, Enrique Castro-Sanchez, Esmita Charani, Frances Davies, Giovanni Satta, Matthew J Ellington, Alison H Holmes |
| 73 |
[GO] |
2020―Mai―18 |
Lopinavir pharmacokinetics in COVID-19 patients |
Matthieu Gregoire, Paul Le Turnier, Benjamin J Gaborit, Gwenaelle Veyrac, Raphaël Lecomte, David Boutoille, Emmanuel Canet, Berthe-Marie Imbert, Ronan Bellouard, François Raffi |
| 74 |
[GO] |
2020―Mrz―06 |
COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression |
Dan Zhou, Sheng-Ming Dai, Qiang Tong |
|
